Other Trials Clinical Trials

Safety, Tolerability and Systemic Absorption of Menadione Topical Lotion for Epidermal-Growth-Factor-Receptor (EGFR) Inhibitor-Associated Rash

This is a clinical research study of an experimental new medication, Menadione Topical Lotion (MTL). The study lotion is experimental and has not been approved for public use. Hana Biosciences, Inc...

Diagnosis: Other Trials

Phase: 1

Protocol Number:

Pharmacokinetic, Safety and Tolerability Study of Recombinant Von Willebrand Factor / Recombinant Factor VIII Complex in Type 3 Von Willebrand Disease

The objectives of this study are to evaluate the immediate tolerability and safety of rVWF:rFVIII in subjects with Type 3 Von Willebrand Disease after administration of various dosages of VWF:RCo.

Diagnosis: Other Trials

Phase:

Protocol Number: 09-239

Randomized Study of a Hospice Video Educational Tool for Patients With Advanced Cancer and Their Caregivers

The purpose of this research study is to compare two ways to educate patients with cancer and their caregivers about hospice care services

Diagnosis: Other Trials

Phase:

Protocol Number: 17-026

Efficacy and Safety of Maribavir in Transplant Recipients With Cytomegalovirus (CMV) Infections That Are Refractory or Resistant to Treatment

The purpose of this study is to determine if an investigational treatment (Maribavir) is safe and effective in treating transplant recipient patients with cytomegalovirus (CMV) infections that are ...

Diagnosis: Other Trials

Phase:

Protocol Number: 17-705

Nelfinavir Mesylate in Treating Patients With Kaposi Sarcoma

This pilot phase II trial studies how well nelfinavir mesylate works in treating patients with kaposi sarcoma. Nelfinavir mesylate may stop the growth of tumor cells by blocking some of the enzymes...

Diagnosis: Cutaneous Skin Cancer, Other Trials

Phase:

Protocol Number: 16-388

A Nurse Led Project to Introduce Hand Lettering as a Form of Art Therapy to Patients in an Ambulatory Oncology Setting

The investigators are conducting a project to provide a new type of resource called "hand lettering" to patients receiving chemotherapy. This is a type of art therapy. The goal of this pr...

Diagnosis: Other Trials

Phase:

Protocol Number: 17-377

Electronic Symptom Monitoring Intervention for Hospitalized Patients With Cancer

This research study is evaluating a new way to deliver oncology care for patients with cancer

Diagnosis: Other Trials

Phase:

Protocol Number: 17-567

Evaluating a Clinician Support Algorithm to Enhance Implementation of Evidence-Based Chemotherapy-Induced Peripheral Neuropathy Assessment and Management Recommendations

This research study is evaluating how well a decision support tool works to improve clinicians' use of recommended chemotherapy-induced peripheral neuropathy (CIPN) assessment and management st...

Diagnosis: Other Trials

Phase:

Protocol Number: 18-049

Phase 2 Study of Ruxolitinib Versus Anagrelide in Subjects With Essential Thrombocythemia Who Are Resistant to or Intolerant of Hydroxyurea (RESET-272)

The purpose of this study is to evaluate the efficacy and safety of ruxolitinib versus anagrelide in subjects with essential thrombocythemia who are resistant to or intolerant of hydroxyurea.

Diagnosis: Other Trials

Phase:

Protocol Number: 17-289

A Study of PRN1008 in Adult Patients With Immune Thrombocytopenic Purpura (ITP)

This is an adaptive, open-label, dose-finding study of PRN1008 in patients with ITP who are refractory or relapsed with no available and approved therapeutic options, with a platelet count <30,0...

Diagnosis: Other Trials

Phase:

Protocol Number: 18-048